GlassScriptPhysician profile
Hetal C Shah
NPI 1750363255
$2,782.58
in general payments reported to CMS, 2019-2025
29 companies · $76.64 in 2025
The $76.64 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $334 · 2021: $899 · 2022: $813 · 2023: $177 · 2024: $248 · 2025: $76.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $784.30 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $448.90 | 2021-2022 | |
| Daiichi Sankyo INC. | $239.59 | 2019-2022 | |
| Gynesonics, INC. | $160.50 | 2022 | |
| Shield Therapeutics INC | $150.00 | 2022-2024 | Accrufer |
| Therapeuticsmd, INC. | $110.61 | 2020-2021 | |
| Aspira Women'S Health INC | $73.92 | 2021-2024 | Ova1 |
| Ethicon US, LLC | $70.75 | 2019-2021 | |
| Coopersurgical, INC. | $65.32 | 2020-2023 | Paragard T 380a |
| Exeltis, USA INC. | $65.26 | 2020-2022 | |
| Hologic Sales and Service, LLC | $61.41 | 2020-2024 | Aptima |
| Evofem Biosciences, INC. | $59.14 | 2021 | |
| Mylan Pharmaceuticals INC. | $55.87 | 2020-2021 | |
| Baxter Healthcare | $55.53 | 2024-2025 | Perclot |
| Merck Sharp & Dohme LLC | $55.52 | 2020-2023 | Gardasil 9 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $53.37 | 2024 | Veozah |
| Channel Medsystems, INC. | $41.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.25 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $29.22 | 2023 | |
| Minerva Surgical, INC | $27.58 | 2020-2023 | |
| Alexion Pharmaceuticals, INC. | $21.87 | 2019 | |
| Abbott Laboratories | $19.84 | 2025 | Octrode |
| Springworks Therapeutics, INC. | $17.88 | 2025 | Gomekli |
| Avion Pharmaceuticals | $15.77 | 2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $15.31 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $13.87 | 2019 | |
| Allergan, INC. | $12.84 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.46 | 2022 | |
| Medtronic, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.